Prescription practices and availability of artemisinin monotherapy in India: where do we stand?

BACKGROUND: The World Health Organization has urged all member states to deploy artemisinin-based combination therapy and progressively withdraw oral artemisinin monotherapies from the market due to their high recrudescence rates and to reduce the risk of drug resistance. Prescription practices by p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Neelima, Anvikar, Anupkumar R, Shah, Naman K, Kamal, Vineet Kumar, Sharma, Surya Kant, Srivastava, Harish Chandra, Das, Manoj Kumar, Pradhan, Khageswar, Kumar, Hemant, Gupta, Yogendra K, Gupta, Pooja, Dash, Aditya Prasad, Valecha, Neena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283503/
https://www.ncbi.nlm.nih.gov/pubmed/22166073
http://dx.doi.org/10.1186/1475-2875-10-360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283503/
https://www.ncbi.nlm.nih.gov/pubmed/22166073
http://dx.doi.org/10.1186/1475-2875-10-360

Ejemplares similares